$CRM Revenue Growth Decelerating. Competition is Intensifying!Salesforce, Inc.BATS:CRMConnectmyCurrencySalesforce built its empire on being the dominant cloud CRM platform. 👑 That dominance is now being challenged from every direction simultaneously. 🔥 Revenue growth has decelerated from over 20% annually to single digit rates. The AI monetisation story has not delivered at the pace the market expected. And the monthly chart has bounced into a clean supply zone. 📊 This is the short entry. 📉 The deceleration is structural, not temporary. 📉 Q1 FY2027 revenue came in at $11.1 billion, up 13% year over year, but a significant portion of that growth was driven by the $444 million Informatica contribution following the acquisition. 💰 Strip out Informatica and organic growth is considerably more modest. 🤔 Full year FY2027 revenue guidance sits at $45.9 billion to $46.2 billion, implying approximately 11% growth in constant currency. 📊 For a company that once grew at 20% to 25% annually, that is a meaningful structural slowdown. ⚠️ The competitive pressure is real and accelerating. ⚡ Microsoft Dynamics and Microsoft Copilot are attacking Salesforce's core enterprise CRM market directly. 🤖 Pure play AI companies are offering workflow automation at a fraction of the cost of Agentforce. Bank of America reiterated an Underperform rating and set a price target of $160, flagging three core issues muted new customer additions, limited room to upsell existing clients, and an underwhelming AI monetisation pathway. 🐻 Citigroup set a price target of $188 on 12 May 2026. These are not fringe views. These are major institutional analysts flagging structural concerns. 💼 The capital allocation tells its own story. 💵 Salesforce commenced a $25 billion accelerated share repurchase, funded by new debt, which reduced Q1 diluted share count by approximately 103 million shares, roughly 11% of outstanding. ♻️ That buyback is boosting EPS optically while the underlying business growth slows. Operating cash flow growth guidance sits at just 4% to 5% year over year for the full year. 📉 The 52 week range sits between $163.52 and $276.80. The stock is trading below its 200 day moving average. 📊 The monthly chart has bounced from the 52 week low area into a clean supply zone. ✅ The bounce is the opportunity. The supply zone is the entry. 📉 🔴 Sell Zone ~ $249.78 area (0.5 Fibonacci Monthly) Monthly supply zone with Fibonacci confluence. Price has bounced from lows into a level where institutional sellers are expected to step in. 📉 Entry (Sell): $249.78 🛑 Stop: $269.50 (7.895% above entry) 🎯 Target: $147.23 (41.1% downside from entry) 📈 Risk/Reward Ratio: 5.2 📅 Next Earnings: 26 August 2026 🌍 52 Week Range: $163.52 to $276.80 🐻 BofA Price Target: $160 Underperform 🐻 Citi Price Target: $188 Revenue growth slowing. 📉 Competition intensifying. 🤖 AI monetisation under scrutiny. ⚠️ The monthly supply zone is the entry. Let price come to the level and let the trade do the work. 🔻 ⚠️ Not financial advice. Manage your risk.